Allied Corp Expands Cannabis Production and Inventory Capacity
KELOWNA, British Columbia, June 03, 2021 (GLOBE NEWSWIRE) -- Allied Corp. ("Allied" or the “Company”) (OTCQB: ALID) an international medical...
Month: June 2021
PDS Biotechnology Expands VERSATILE-002 study of PDS0101 and KEYTRUDA® in Advanced Head and Neck Cancer to Include Patients Who Have Failed Prior Treatment with Checkpoint Inhibitors
FLORHAM PARK, N.J., June 03, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel...
Nova Leap Health Corp. Announces Oversubscribed Non-Brokered Private Placement of Common Shares and Increase in Offering
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER...
Marrone Bio Innovations Partners with ATP Nutrition to Distribute Stargus® Biofungicide in Canada
Agreement Marks Expansion into the Broad Acre Crops MarketDAVIS, Calif., June 03, 2021 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc....
Cue Biopharma to Present at the 2021 Federation of Clinical Immunology Societies (FOCIS) Virtual Annual Meeting
CAMBRIDGE, Mass., June 03, 2021 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company engineering a novel...
Align Technology Releases iTero Workflow 2.0 Software and Previews New iTero Element 5D Imaging System Auto-Upload Functionality
Newly released iTero Workflow 2.0 software features include faster scanning, improved visualization, and enhanced patient communication tools that help increase...
Visionology Acquires Exclusive Worldwide License to SPARCS Contrast Sensitivity Testing Technology
Patented Software to Aid in Identifying Eye Disease and Remotely Monitoring Eye HealthNASHVILLE, Tenn., June 03, 2021 (GLOBE NEWSWIRE) --...
Aeterna Zentaris Announces Final Settlement of Previously Disclosed Class-Action Lawsuit
CHARLESTON, S.C., June 03, 2021 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a...
Resverlogix and EVERSANA Announce Partnership to Support the Pending Launch of the Initial Commercialization of Apabetalone for COVID-19 in the United States and Canada
CALGARY, Alberta and CHICAGO, June 03, 2021 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix") (TSX:RVX) and EVERSANA™, the pioneer of next generation...
Predictmedix Inc. Deploys Safe Entry Stations at the Italian Contemporary Film Festival
TORONTO, June 03, 2021 (GLOBE NEWSWIRE) -- Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) ("Predictmedix" or the "Company"), is pleased to announce the...
Sanofi launches €3 million Planet Mobilization fund to support employees’ environmental projects
Sanofi launches €3 million Planet Mobilization fund to support employees’ environmental projects This year, Sanofi will fund three employee teams...
Enlivex to Present at the Jefferies 2021 Virtual Healthcare Conference
Nes Ziona, Israel, June 03, 2021 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming...
Avadel to Present New Efficacy and Safety Data from Pivotal Phase 3 REST-ON Trial of FT218 at SLEEP 2021
DUBLIN, Ireland, June 03, 2021 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on developing FT218, an...
Equillium to Host Conference Call Following Presentation of Data from the EQUATE Study in Acute Graft Versus Host Disease at the EHA2021 Virtual Congress of the European Hematology Association on June 11
Presentation and conference call will include topline data from all cohorts The risk-benefit profile observed supports advancing development of itolizumab...
Monopar Announces New Drug Candidate, MNPR-202, and Enters into Collaboration Agreement with the National University of Singapore for Preclinical Evaluation in Cancer
Development of novel Camsirubicin analog expands Monopar’s therapeutic pipelineWILMETTE, Ill., June 03, 2021 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a...
Stellanova Therapeutics, Inc. Announces Closing of $15.5 Million Series A Financing
Proceeds will support development of antibody drugs and discovery platform targeting pro-tumorigenic factors produced by fibroblasts in the tumor microenvironment,...
Oyster Point Pharma Announces Preclinical Study Results and Pipeline Expansion with Enriched Tear Film (ETF™) Gene Therapy to Target Ocular Surface Diseases
Introduction of proprietary ETF™ Gene Therapy and first gene candidate, nerve growth factor (NGF), to target Stages 2 and 3...
Motus GI Announces Publication of Pure-Vu® System Clinical Data in Peer-Reviewed Journal BMC Gastroenterology
FORT LAUDERDALE, Fla., June 03, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"),...
Krystal Biotech to Participate in Upcoming Investor Conferences
PITTSBURGH, June 03, 2021 (GLOBE NEWSWIRE) -- Krystal Biotech Inc., (“Krystal”) (NASDAQ: KRYS), the leader in redosable gene therapies for...
Summit Therapeutics’ Upcoming Annual Shareholders’ Meeting
Cambridge, MA, June 03, 2021 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) invites our shareholders and other interested parties...